214 related articles for article (PubMed ID: 37202390)
1. FBXW7β loss-of-function enhances FASN-mediated lipogenesis and promotes colorectal cancer growth.
Wei W; Qin B; Wen W; Zhang B; Luo H; Wang Y; Xu H; Xie X; Liu S; Jiang X; Wang M; Tang Q; Zhang J; Yang R; Fan Z; Lyu H; Lin J; Li K; Lee MH
Signal Transduct Target Ther; 2023 May; 8(1):187. PubMed ID: 37202390
[TBL] [Abstract][Full Text] [Related]
2. Destabilization of Fatty Acid Synthase by Acetylation Inhibits De Novo Lipogenesis and Tumor Cell Growth.
Lin HP; Cheng ZL; He RY; Song L; Tian MX; Zhou LS; Groh BS; Liu WR; Ji MB; Ding C; Shi YH; Guan KL; Ye D; Xiong Y
Cancer Res; 2016 Dec; 76(23):6924-6936. PubMed ID: 27758890
[TBL] [Abstract][Full Text] [Related]
3. Tissue-Specific Downregulation of Fatty Acid Synthase Suppresses Intestinal Adenoma Formation via Coordinated Reprograming of Transcriptome and Metabolism in the Mouse Model of Apc-Driven Colorectal Cancer.
Drury J; Young LEA; Scott TL; Kelson CO; He D; Liu J; Wu Y; Wang C; Weiss HL; Fan T; Gentry MS; Sun R; Zaytseva YY
Int J Mol Sci; 2022 Jun; 23(12):. PubMed ID: 35742953
[TBL] [Abstract][Full Text] [Related]
4. ERK2-Dependent Phosphorylation of CSN6 Is Critical in Colorectal Cancer Development.
Fang L; Lu W; Choi HH; Yeung SC; Tung JY; Hsiao CD; Fuentes-Mattei E; Menter D; Chen C; Wang L; Wang J; Lee MH
Cancer Cell; 2015 Aug; 28(2):183-97. PubMed ID: 26267535
[TBL] [Abstract][Full Text] [Related]
5. Cancer cell-associated fatty acid synthase activates endothelial cells and promotes angiogenesis in colorectal cancer.
Zaytseva YY; Elliott VA; Rychahou P; Mustain WC; Kim JT; Valentino J; Gao T; O'Connor KL; Neltner JM; Lee EY; Weiss HL; Evers BM
Carcinogenesis; 2014 Jun; 35(6):1341-51. PubMed ID: 24510238
[TBL] [Abstract][Full Text] [Related]
6. Inhibition of fatty acid synthase attenuates CD44-associated signaling and reduces metastasis in colorectal cancer.
Zaytseva YY; Rychahou PG; Gulhati P; Elliott VA; Mustain WC; O'Connor K; Morris AJ; Sunkara M; Weiss HL; Lee EY; Evers BM
Cancer Res; 2012 Mar; 72(6):1504-17. PubMed ID: 22266115
[TBL] [Abstract][Full Text] [Related]
7. FABP5 suppresses colorectal cancer progression via mTOR-mediated autophagy by decreasing FASN expression.
Ye M; Hu C; Chen T; Yu P; Chen J; Lu F; Xu L; Zhong Y; Yan L; Kan J; Bai J; Li X; Tian Y; Tang Q
Int J Biol Sci; 2023; 19(10):3115-3127. PubMed ID: 37416772
[TBL] [Abstract][Full Text] [Related]
8. CSN6-TRIM21 axis instigates cancer stemness during tumorigenesis.
Qin B; Zou S; Li K; Wang H; Wei W; Zhang B; Xiao L; Choi HH; Tang Q; Huang D; Liu Q; Pan Q; Meng M; Fang L; Lee MH
Br J Cancer; 2020 May; 122(11):1673-1685. PubMed ID: 32225170
[TBL] [Abstract][Full Text] [Related]
9. Fatty Acid Synthase-Suppressor Screening Identifies Sorting Nexin 8 as a Therapeutic Target for NAFLD.
Hu Y; He W; Huang Y; Xiang H; Guo J; Che Y; Cheng X; Hu F; Hu M; Ma T; Yu J; Tian H; Tian S; Ji YX; Zhang P; She ZG; Zhang XJ; Huang Z; Yang J; Li H
Hepatology; 2021 Nov; 74(5):2508-2525. PubMed ID: 34231239
[TBL] [Abstract][Full Text] [Related]
10. Enhanced De Novo Lipid Synthesis Mediated by FASN Induces Chemoresistance in Colorectal Cancer.
Han L; Dai W; Luo W; Ye L; Fang H; Mo S; Li Q; Xu Y; Wang R; Cai G
Cancers (Basel); 2023 Jan; 15(3):. PubMed ID: 36765520
[TBL] [Abstract][Full Text] [Related]
11. FASN-dependent de novo lipogenesis is required for brain development.
Gonzalez-Bohorquez D; Gallego López IM; Jaeger BN; Pfammatter S; Bowers M; Semenkovich CF; Jessberger S
Proc Natl Acad Sci U S A; 2022 Jan; 119(2):. PubMed ID: 34996870
[TBL] [Abstract][Full Text] [Related]
12. BCAT2 promotes melanoma progression by activating lipogenesis via the epigenetic regulation of FASN and ACLY expressions.
Tian Y; Ma J; Wang H; Yi X; Wang H; Zhang H; Guo S; Yang Y; Zhang B; Du J; Shi Q; Gao T; Guo W; Li C
Cell Mol Life Sci; 2023 Oct; 80(11):315. PubMed ID: 37801083
[TBL] [Abstract][Full Text] [Related]
13. FASN promotes gallbladder cancer progression and reduces cancer cell sensitivity to gemcitabine through PI3K/AKT signaling.
Cheng H; Sun Y; Yu X; Zhou D; Ding J; Wang S; Ma F
Drug Discov Ther; 2023 Nov; 17(5):328-339. PubMed ID: 37743521
[TBL] [Abstract][Full Text] [Related]
14. COP9 signalosome subunit 6 stabilizes COP1, which functions as an E3 ubiquitin ligase for 14-3-3σ.
Choi HH; Gully C; Su CH; Velazquez-Torres G; Chou PC; Tseng C; Zhao R; Phan L; Shaiken T; Chen J; Yeung SC; Lee MH
Oncogene; 2011 Dec; 30(48):4791-801. PubMed ID: 21625211
[TBL] [Abstract][Full Text] [Related]
15. Blockade of fatty acid synthase induces ubiquitination and degradation of phosphoinositide-3-kinase signaling proteins in ovarian cancer.
Tomek K; Wagner R; Varga F; Singer CF; Karlic H; Grunt TW
Mol Cancer Res; 2011 Dec; 9(12):1767-79. PubMed ID: 21970855
[TBL] [Abstract][Full Text] [Related]
16. Preclinical evaluation of novel fatty acid synthase inhibitors in primary colorectal cancer cells and a patient-derived xenograft model of colorectal cancer.
Zaytseva YY; Rychahou PG; Le AT; Scott TL; Flight RM; Kim JT; Harris J; Liu J; Wang C; Morris AJ; Sivakumaran TA; Fan T; Moseley H; Gao T; Lee EY; Weiss HL; Heuer TS; Kemble G; Evers M
Oncotarget; 2018 May; 9(37):24787-24800. PubMed ID: 29872506
[TBL] [Abstract][Full Text] [Related]
17. Fatty acid synthase regulates invasion and metastasis of colorectal cancer via Wnt signaling pathway.
Wang H; Xi Q; Wu G
Cancer Med; 2016 Jul; 5(7):1599-606. PubMed ID: 27139420
[TBL] [Abstract][Full Text] [Related]
18. Differential requirement for de novo lipogenesis in cholangiocarcinoma and hepatocellular carcinoma of mice and humans.
Li L; Che L; Tharp KM; Park HM; Pilo MG; Cao D; Cigliano A; Latte G; Xu Z; Ribback S; Dombrowski F; Evert M; Gores GJ; Stahl A; Calvisi DF; Chen X
Hepatology; 2016 Jun; 63(6):1900-13. PubMed ID: 26910791
[TBL] [Abstract][Full Text] [Related]
19. eIF3f Mediates SGOC Pathway Reprogramming by Enhancing Deubiquitinating Activity in Colorectal Cancer.
Pan Q; Yu F; Jin H; Zhang P; Huang X; Peng J; Xie X; Li X; Ma N; Wei Y; Wen W; Zhang J; Zhang B; Yu H; Xiao Y; Liu RY; Liu Q; Meng X; Lee MH
Adv Sci (Weinh); 2023 Sep; 10(27):e2300759. PubMed ID: 37544925
[TBL] [Abstract][Full Text] [Related]
20.
Czumaj A; Zabielska J; Pakiet A; Mika A; Rostkowska O; Makarewicz W; Kobiela J; Sledzinski T; Stelmanska E
Anticancer Res; 2019 Jul; 39(7):3815-3822. PubMed ID: 31262909
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
